Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SMMT | NBIX | IONS | ||
| Company | Summit Therapeu ADR | Neurocrine Bioscienc | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.74 | 129.48 | 73.12 | ||
| High | 17.54 | 130.10 | 73.21 | ||
| Low | 16.74 | 128.20 | 71.48 | ||
| Latest | 16.98 | 128.72 | 72.52 | ||
| Change | +0.40 | +0.40 | +0.37 | ||
| % Change | +2.41% | +0.31% | +0.51% | ||
| Volume | 2,688,500 | 740,500 | 2,045,400 | ||
| 20-Day Average Volume | 2,552,545 | 975,495 | 2,461,590 | ||
| Previous Close | 16.58 | 128.32 | 72.15 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.95 | 129.67 | 73.37 | ||
| 20-Day Raw Stochastic | 65.38% | 37.14% | 28.96% | ||
| 20-Day Relative Strength | 54.73 | 45.64 | 42.49 | ||
| Weighted Alpha | +0.32 | +19.68 | +91.81 | ||
| Today's Opinion | 24% Sell | 88% Sell | 8% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 8% Sell | ||
| Last Month's Opinion | 72% Sell | 72% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.85% since 03/23/26 | +1.31% since 03/23/26 | +2.44% since 03/23/26 | ||
| Low | 15.36 on 03/24/26 | 125.11 on 03/24/26 | 68.90 on 03/24/26 | ||
| High | 18.24 on 03/26/26 | 133.04 on 03/25/26 | 75.63 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +2.35% since 02/27/26 | -2.67% since 02/27/26 | -10.63% since 02/27/26 | ||
| Low | 14.60 on 03/06/26 | 125.11 on 03/24/26 | 68.90 on 03/24/26 | ||
| High | 18.24 on 03/26/26 | 134.83 on 03/04/26 | 82.75 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -6.39% since 12/26/25 | -11.39% since 12/26/25 | -9.27% since 12/26/25 | ||
| Low | 13.83 on 02/05/26 | 122.14 on 02/12/26 | 68.90 on 03/24/26 | ||
| High | 20.20 on 01/09/26 | 145.51 on 12/29/25 | 86.74 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | -18.95% since 09/26/25 | -9.35% since 09/26/25 | +13.15% since 09/26/25 | ||
| Low | 13.83 on 02/05/26 | 122.14 on 02/12/26 | 63.36 on 09/29/25 | ||
| High | 25.49 on 10/13/25 | 160.18 on 12/08/25 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,855,684 | 12,878,580 | 11,918,604 | ||
| Shares Outstanding, K | 775,373 | 100,363 | 165,192 | ||
| Annual Sales | 0 | 2,860,500,000 | 943,710,000 | ||
| Annual Net Income | -1,079,590,000 | 478,600,000 | -381,390,000 | ||
| Last Quarter Sales | 0 | 805,500,000 | 203,330,000 | ||
| Last Quarter Net Income | -219,170,000 | 153,700,000 | -229,390,000 | ||
| 60-Month Beta | -1.43 | 0.32 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 02/23/26 | 1.88 on 02/11/26 | -1.14 on 02/25/26 | ||
| Latest Earnings Date | 05/07/26 | 05/04/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.72 | 0.00 | ||